Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
J Neurochem
    February 2026
  1. GIAMBARTOLOMEI GH, Iribarren P, Pasquini LA, Peluffo H, et al
    Microglia at the Forefront: New Insights From the Glial Club South Cone Meeting 2025.
    J Neurochem. 2026;170:e70384.
    >> Share

  2. BARAL R, van Deventer R, Lyubchenko YL
    Amyloid beta-Cholesterol Interplay: Removal of Cholesterol From the Membranes to Catalyze Aggregation and Amyloid Pathology.
    J Neurochem. 2026;170:e70380.
    >> Share

  3. RUANKHAM W, Prachayasittikul V, Pingaew R, Jeungprasopsuk W, et al
    Unraveling Network Pharmacology-Based Therapeutics of Anthranilate Sulfonamides via Sirtuins/FOXO3a Cascade in Alzheimer's Disease.
    J Neurochem. 2026;170:e70377.
    >> Share

  4. GAO Z, Wang Y, Ren Y, Lyu J, et al
    Integrated Bioinformatics Analysis of Screen Mitochondrial Autophagy-Related Core Genes and Construct Diagnostic Model for Alzheimer's Disease.
    J Neurochem. 2026;170:e70387.
    >> Share

    December 2025
  5. DULEWICZ M, Kac PR, Ortiz FG, Karikari TK, et al
    Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.
    J Neurochem. 2025;169:e70313.
    >> Share

  6. KOUTARAPU S, Roberts KF, Coyle RA, Mehla J, et al
    Post-Translational Modifications Distinguish Amyloid-beta Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    J Neurochem. 2025;169:e70335.
    >> Share

    November 2025
  7. BESCHORNER N, Xu Y, Jucker M, Ruiz-Riquelme A, et al
    Amyloid-beta Seeds in Alzheimer's Disease: Research Challenges and Implications.
    J Neurochem. 2025;169:e70267.
    >> Share

  8. CONSTANTINO NJ, Ashley CC, Macauley SL
    The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks.
    J Neurochem. 2025;169:e70294.
    >> Share

  9. PEREZ-RAMIREZ R, Cuchillo-Ibanez I, Sanchez-Romero R, Beltran-Sanahuja A, et al
    Development and Validation of an ICP-MS/MS Method for the Multielemental Analysis of Cerebrospinal Fluid, Examination of Alzheimer's Disease Samples.
    J Neurochem. 2025;169:e70307.
    >> Share

    October 2025
  10. CHU X, Guo Y, Fu Y, Ren H, et al
    An Amino Acid and Carnitine Metabolite Profile for the Early Detection and Differential Diagnosis of Alzheimer's Disease.
    J Neurochem. 2025;169:e70234.
    >> Share

  11. SANCHEZ DE MUNIAIN L, Escalada P, Ramirez MJ, Solas M, et al
    Astrocytes as Metabolic Sensors Orchestrating Energy-Driven Brain Vulnerability in Alzheimer's Disease.
    J Neurochem. 2025;169:e70252.
    >> Share

    September 2025
  12. SMITH ED, Torrellas J, McKenna R, Vo Q, et al
    Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation.
    J Neurochem. 2025;169:e70221.
    >> Share

  13. MALARTE ML, Chiotis K, Ioannou K, Rodriguez-Vieitez E, et al
    Peripheral Inflammation Is Associated With Greater Neuronal Injury and Lower Episodic Memory Among Late Middle-Aged Adults.
    J Neurochem. 2025;169:e70222.
    >> Share

  14. ZHAO J, Chen J, Lu J, Shi Q, et al
    Nitration of Tyrosine Residue Y10 of Abeta(1-42) Ameliorates Abeta(1-42)-Induced Neurotoxicity and Memory Impairment In Vitro and In Vivo.
    J Neurochem. 2025;169:e70218.
    >> Share

    August 2025
  15. HARDY J
    Alzheimer's Disease: Treatment Challenges for the Future.
    J Neurochem. 2025;169:e70176.
    >> Share

  16. SCHIFANI C, Anderson JAE, Nazeri A, Voineskos AN, et al
    In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly.
    J Neurochem. 2025;169:e70167.
    >> Share

  17. BUCCI M, Almkvist O, Bluma M, Ashton NJ, et al
    Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Abeta42, and Their Relation to Cognition in Memory Clinic Patients.
    J Neurochem. 2025;169:e70182.
    >> Share

  18. TEIXEIRA LCR, Pereira JD, Mamede I, Caramelli P, et al
    Common miRNAs, Genes, and Regulatory Pathways in Alzheimer's Disease and Type 2 Diabetes Mellitus: An Integrative Analysis of Systematic Reviews, Bioinformatics and Data Mining.
    J Neurochem. 2025;169:e70196.
    >> Share

  19. LI HY, Deng YT, Guo Y, Zhang Y, et al
    Clinical Utility of Plasma GFAP and NEFL as Biomarkers for Dementia in the Community.
    J Neurochem. 2025;169:e70210.
    >> Share

  20. HAO Q, Fu Y, Zhao YL, Zhang ZQ, et al
    Association Between Phenoage With Cognitive Function and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology: The CABLE Study.
    J Neurochem. 2025;169:e70174.
    >> Share

  21. DA CONCEICAO ARR, Marinatto J, Pinheiro LS, Rody T, et al
    The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease.
    J Neurochem. 2025;169:e70209.
    >> Share

  22. ESCAMILLA S, Perez-Gonzalez R, Marquez-Marco C, Camporesi E, et al
    Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.
    J Neurochem. 2025;169:e70192.
    >> Share

    July 2025
  23. HARDY J
    Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease.
    J Neurochem. 2025;169:e70148.
    >> Share

  24. CHEN Y, Albert AL, Sehrawat A, Farinas MF, et al
    Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays.
    J Neurochem. 2025;169:e70114.
    >> Share

  25. HU S, Zhu P, Gao S, Wu S, et al
    Self-Report Alzheimer's Disease Statuses in UK Biobank Distort Downstream Analyses.
    J Neurochem. 2025;169:e70151.
    >> Share

  26. BEZERRA IC, Dos Santos ERS, do Nascimento KGA, da Silva AJ, et al
    Label-Free Proteomic Profiling of the dvls2 (CL2006) Caenorhabditis elegans Alzheimer's Disease (AD) Model Reveals Conserved Molecular Signatures Shared With the Human AD Brain.
    J Neurochem. 2025;169:e70152.
    >> Share

    June 2025
  27. LAU V, VanderZwaag J, Murray CJ, Tremblay ME, et al
    Exploring Iron Deposition Patterns Using Light and Electron Microscopy in the Mouse Brain Across Aging and Alzheimer's Disease Pathology Conditions.
    J Neurochem. 2025;169:e70086.
    >> Share

  28. KOTOVA MM, Stewart AM, Grigoryan A, Shariff S, et al
    Towards Better and More Valid Zebrafish Models of Alzheimer's Disease: A Scientific Tribute to Prof. Mikhail I. Aghajanov.
    J Neurochem. 2025;169:e70090.
    >> Share

    May 2025
  29. NAGAI-ARAKAWA I, Muramatsu I, Uwada J, Tsuda Y, et al
    Evaluation of the Alterations in Central Cholinergic Neurotransmission in Aging and Amyloid Precursor Protein Knock-In Mice.
    J Neurochem. 2025;169:e70081.
    >> Share

    April 2025
  30. REHMAN AS, Tasleem A, Ali N, Khan R, et al
    Donepezil Improves PSD95 Expression, Mitigates Neuroinflammation via PI3K/Akt/NF-kappaB and Mitochondrial Dysfunction in a Rodent Model of Subarachnoid Haemorrhage.
    J Neurochem. 2025;169:e70063.
    >> Share

    March 2025
  31. BONG SH, Choi H, Song HH, Kim DK, et al
    Metabolic Reprogramming in Primary Microglial Cell and Extracellular Vesicle Triggered by Abeta Exposure.
    J Neurochem. 2025;169:e70030.
    >> Share

  32. YANG J, Pu YL, Pan QL, Wang L, et al
    CPNE7 Regulates Amyloidogenesis Through CAP1-Dependent ADAM10 Translation.
    J Neurochem. 2025;169:e70026.
    >> Share

  33. AL-THANI NA, Stewart GS, Costello DA
    The Role of the Urea Cycle in the Alzheimer's Disease Brain.
    J Neurochem. 2025;169:e70033.
    >> Share

  34. HEYLEN A, Vermeiren Y, De Deyn PP, Van Dam D, et al
    Monoaminergic Alterations at the Subregional Cervical and Thoracic Spinal Cord Level of Patients Within the FTD-ALS Continuum and Early-Onset AD: Low Thoracic Dopaminergic Activity in ALS.
    J Neurochem. 2025;169:e70046.
    >> Share

  35. ALSHAEBI F, Sciortino A, Kayed R
    The Role of Glial Cell Senescence in Alzheimer's Disease.
    J Neurochem. 2025;169:e70051.
    >> Share

    February 2025
  36. FU X, Quan S, Liang W, Li Y, et al
    FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.
    J Neurochem. 2025;169:e70011.
    >> Share

  37. NOVACK GV, Galeano P, Defelipe LA, Campanelli L, et al
    The Supramolecular Architecture of Mitochondrial Complex I in the Rat Brain Is Altered by Alzheimer's-Like Cerebral Amyloidosis.
    J Neurochem. 2025;169:e70017.
    >> Share

  38. DIVYA, Faruq M, Nazir SS, Kaushik P, et al
    Ganaxolone Reverses the Effect of Amyloid beta-Induced Neurotoxicity by Regulating the Liver X Receptor Expression in APP Transfected SH-SY5Y Cells and Murine Model of Alzheimer's Disease.
    J Neurochem. 2025;169:e70007.
    >> Share

  39. TISI A, Scipioni L, Carozza G, Di Re L, et al
    Alterations of endocannabinoid signaling and microglia reactivity in the retinas of AD-like mice precede the onset of hippocampal beta-amyloid plaques.
    J Neurochem. 2025;169:e16256.
    >> Share

  40. SHARMIN T, Chatterjee P, Doecke JD, Ashton NJ, et al
    Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.
    J Neurochem. 2025;169:10.
    >> Share

    January 2025
  41. ELSWORTHY RJ, Finelli MJ, Aqattan S, Dunleavy C, et al
    Altered metabolic function induced by Abeta-oligomers and PSEN1 mutations in iPSC-derived astrocytes.
    J Neurochem. 2025;169:e16267.
    >> Share

  42. MENG J, Lei P
    Testing cognitive normal for Alzheimer's disease prediction.
    J Neurochem. 2025;169:e16272.
    >> Share

  43. TSERING W, de la Rosa A, Ruan IY, Philips JL, et al
    Preferential clustering of microglia and astrocytes around neuritic plaques during progression of Alzheimer's disease neuropathological changes.
    J Neurochem. 2025;169:e16275.
    >> Share

  44. HE Y, Zhu P, Gao S, Wu S, et al
    Identification of Alzheimer's disease susceptibility genes by integrating eight human brain single-cell transcriptomes with genome-wide association studies.
    J Neurochem. 2025;169:e16276.
    >> Share


  45. EXPRESSION OF CONCERN: Potent Anti-amyloidogenic and Fibril-destabilizing Effects of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of Alzheimer's Disease.
    J Neurochem. 2025;169:e16285.
    >> Share

  46. PFITZER J, Pinky PD, Perman S, Redmon E, et al
    Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and synaptic and memory impairments in 3xTg-AD mice.
    J Neurochem. 2025;169:e16215.
    >> Share

  47. WANG YC, Huang LY, Guo HH, Liu M, et al
    Higher CSF sTREM2 attenuates APOE epsilon4-related risk for amyloid pathology in cognitively intact adults: The CABLE study.
    J Neurochem. 2025;169:e16273.
    >> Share

  48. PAWLOSKY R, Demarest TG, King MT, Estrada D, et al
    Effect of Dietary Ketosis and Nicotinamide Riboside on Hippocampal Krebs Cycle Intermediates and Mitochondrial Energetics in a DNA Repair-Deficient 3xTg/POLbeta(+/-) Alzheimer Disease Mouse Model.
    J Neurochem. 2025;169:e16295.
    >> Share

  49. ROHR D, Helfrich M, Horing M, Grosseruschkamp F, et al
    Unsaturated Fatty Acids Are Decreased in Abeta Plaques in Alzheimer's Disease.
    J Neurochem. 2025;169:e16306.
    >> Share

    November 2024
  50. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Elevated serum sodium is linked to increased amyloid-dependent tau pathology, neurodegeneration, and cognitive impairment in Alzheimer's disease.
    J Neurochem. 2024 Nov 6. doi: 10.1111/jnc.16257.
    >> Share

    October 2024
  51. XU F, Wu S, Gao S, Li X, et al
    Causal association between insulin sensitivity index and Alzheimer's disease.
    J Neurochem. 2024 Oct 31. doi: 10.1111/jnc.16254.
    >> Share

    September 2024
  52. MITIAS S, Schaffer N, Nair S, Hook C, et al
    ProSAAS is preferentially up-regulated during homeostatic scaling and reduces amyloid plaque burden in the 5xFAD mouse hippocampus.
    J Neurochem. 2024;168:3235-3249.
    >> Share

  53. STROPE TA, Wilkins HM
    The reciprocal relationship between amyloid precursor protein and mitochondrial function.
    J Neurochem. 2024;168:2275-2284.
    >> Share

  54. XIONG M, Dahlen A, Roshanbin S, Wik E, et al
    Antibody engagement with amyloid-beta does not inhibit [(11)C]PiB binding for PET imaging.
    J Neurochem. 2024;168:2601-2610.
    >> Share

  55. MA LY, Song JH, Gao PY, Ou YN, et al
    Amyloid pathology mediates the associations between plasma fibrinogen and cognition in non-demented adults.
    J Neurochem. 2024;168:2532-2542.
    >> Share

  56. LOGSDON AF, Foresi B, Hu SJ, Quah E, et al
    Perineuronal net deglycosylation associates with tauopathy-induced gliosis and neurodegeneration.
    J Neurochem. 2024;168:1923-1936.
    >> Share

  57. AMONTREE M, Nelson M, Stefansson L, Pak D, et al
    Resveratrol differentially affects MMP-9 release from neurons and glia; implications for therapeutic efficacy.
    J Neurochem. 2024;168:1895-1908.
    >> Share

    July 2024
  58. DEN HOEDT S, Crivelli SM, Dorst-Lagerwerf KY, Leijten FPJ, et al
    The effects of APOE4 and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age- and sex-dependent.
    J Neurochem. 2024 Jul 13. doi: 10.1111/jnc.16176.
    >> Share

  59. HUANG HX, Inglese P, Tang J, Yagoubi R, et al
    Mass spectrometry imaging highlights dynamic patterns of lipid co-expression with Abeta plaques in mouse and human brains.
    J Neurochem. 2024;168:1193-1214.
    >> Share

  60. VAN DEN BERG E, Kersten I, Brinkmalm G, Johansson K, et al
    Profiling amyloid-beta peptides as biomarkers for cerebral amyloid angiopathy.
    J Neurochem. 2024;168:1254-1264.
    >> Share

    June 2024
  61. ISEI MO, Girardi PA, Rodwell-Bullock J, Nehrke K, et al
    Site-specific phosphorylation of tau impacts mitochondrial function and response to stressors.
    J Neurochem. 2024;168:1019-1029.
    >> Share

    May 2024
  62. CHEN Y, Zeng X, Diaz JL, Sehrawat A, et al
    Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer's disease plasma biomarkers.
    J Neurochem. 2024 May 30. doi: 10.1111/jnc.16130.
    >> Share

    April 2024

  63. The following article for this Special Issue was previously published and can be found in its respective issue online: "Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4".
    J Neurochem. 2024;168:e2.
    >> Share

  64. KWAN KH, Soreq H
    EDITOR SPOTLIGHT: Interview with Cholinergic Mechanisms Special Issue Guest Editor Hermona Soreq.
    J Neurochem. 2024;168:331-333.
    >> Share

    March 2024
  65. NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
    Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases.
    J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
    >> Share

  66. ZHANG JF, Fang ZT, Zhao JN, Liu GP, et al
    Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells.
    J Neurochem. 2024;168:288-302.
    >> Share

    February 2024
  67. PEREIRA JD, Teixeira LCR, Mamede I, Alves MT, et al
    miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
    J Neurochem. 2024 Feb 23. doi: 10.1111/jnc.16060.
    >> Share

  68. HANRIEDER J
    Lipid imaging of Alzheimer's disease pathology.
    J Neurochem. 2024 Feb 19. doi: 10.1111/jnc.16079.
    >> Share

  69. FERNANDES T, Melo T, Conde T, Neves B, et al
    Mapping the lipidome in mitochondria-associated membranes (MAMs) in an in vitro model of Alzheimer's disease.
    J Neurochem. 2024 Feb 7. doi: 10.1111/jnc.16072.
    >> Share

  70. LIANG Y, Deng MG, Jian Q, Liu M, et al
    Maternal history of Alzheimer's disease predisposes to altered serum cholesterol levels in adult offspring.
    J Neurochem. 2024 Feb 5. doi: 10.1111/jnc.16056.
    >> Share

  71. SU M, Xuan E, Sun X, Pan G, et al
    Synaptic adhesion molecule protocadherin-gammaC5 mediates beta-amyloid-induced neuronal hyperactivity and cognitive deficits in Alzheimer's disease.
    J Neurochem. 2024 Feb 3. doi: 10.1111/jnc.16066.
    >> Share

  72. FRANCIS JS, Nguyen Q, Markov V, Leone P, et al
    Over-expression of N-acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse.
    J Neurochem. 2024;168:69-82.
    >> Share

    December 2023
  73. SALCEDO C, Pozo Garcia V, Garcia-Adan B, Ameen AO, et al
    Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC-derived models of Alzheimer's disease.
    J Neurochem. 2023 Dec 8. doi: 10.1111/jnc.16014.
    >> Share

  74. GAO PY, Ou YN, Huang YM, Wang ZB, et al
    Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study.
    J Neurochem. 2023 Dec 6. doi: 10.1111/jnc.16025.
    >> Share

  75. HUANG SY, Zhang YR, Yang L, Li YZ, et al
    Circulating metabolites and risk of incident dementia: A prospective cohort study.
    J Neurochem. 2023;167:668-679.
    >> Share

    November 2023
  76. QIN H, Zhou L, Haque FT, Martin-Jimenez C, et al
    Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease.
    J Neurochem. 2023 Nov 6. doi: 10.1111/jnc.16002.
    >> Share

  77. HAMILTON K, Morrow K, Markantoni E, Harvey J, et al
    Leptin prevents aberrant targeting of tau to hippocampal synapses via PI 3 kinase driven inhibition of GSK3beta.
    J Neurochem. 2023;167:520-537.
    >> Share

    October 2023
  78. FURMAN S, Green K, Lane TE
    COVID-19 and the impact on Alzheimer's disease pathology.
    J Neurochem. 2023 Oct 18. doi: 10.1111/jnc.15985.
    >> Share

  79. TURNER AJ
    Book Review: Alzheimer's Disease Research: What has guided research so far and why it is high time for a paradigm shift (Christian Behl. Springer Nature, Switzerland, 2023) 661 pp.
    J Neurochem. 2023 Oct 14. doi: 10.1111/jnc.15989.
    >> Share

  80. SAMUELS JD, Lukens JR, Price RJ
    Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease-related amyloidosis.
    J Neurochem. 2023 Oct 11. doi: 10.1111/jnc.15981.
    >> Share

    September 2023
  81. WANG R, Lu KP, Zhou XZ
    Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies.
    J Neurochem. 2023;166:904-914.
    >> Share

  82. SAEZ-VALERO J, Perez-Gonzalez R
    BACE2 beyond beta-processing of APP, its neuroprotective role in cerebrovascular endothelium.
    J Neurochem. 2023;166:887-890.
    >> Share

  83. CHENG JY, Deng YT, Yu JT
    The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    J Neurochem. 2023;166:972-981.
    >> Share

    August 2023
  84. LAU SF, Fu AKY, Ip NY
    Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology.
    J Neurochem. 2023 Aug 21. doi: 10.1111/jnc.15933.
    >> Share

  85. CUENCA-BERMEJO L, Prinetti A, Kublickiene K, Raparelli V, et al
    Fundamental neurochemistry review: Old brain stories - Influence of age and sex on the neurodegeneration-associated lipid changes.
    J Neurochem. 2023;166:427-452.
    >> Share

    July 2023
  86. WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al
    Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
    J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924.
    >> Share

  87. RAI A, Ojiakor OA, Rylett RJ
    Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4.
    J Neurochem. 2023 Jul 6. doi: 10.1111/jnc.15904.
    >> Share

  88. MOREIRA GG, Gomes CM
    Tau liquid-liquid phase separation is modulated by the Ca(2+) -switched chaperone activity of the S100B protein.
    J Neurochem. 2023;166:76-86.
    >> Share

  89. MATAFORA V, Gorb A, Yang F, Noble W, et al
    Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Abeta.
    J Neurochem. 2023;166:346-366.
    >> Share

  90. SECKER C, Motzny AY, Kostova S, Buntru A, et al
    The polyphenol EGCG directly targets intracellular amyloid-beta aggregates and promotes their lysosomal degradation.
    J Neurochem. 2023;166:294-317.
    >> Share

  91. SANTIAGO TC, Parra L, Nani JV, Fidalgo TM, et al
    Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders.
    J Neurochem. 2023;166:138-155.
    >> Share

    June 2023
  92. ANDERSON T, Sharma S, Kelberman MA, Ware C, et al
    Obesity during preclinical Alzheimer's disease development exacerbates brain metabolic decline.
    J Neurochem. 2023 Jun 30. doi: 10.1111/jnc.15900.
    >> Share

  93. MAKSOUR S, Ooi L
    Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models.
    J Neurochem. 2023 Jun 15. doi: 10.1111/jnc.15885.
    >> Share

  94. ZHAO Y, Zhou H, Zhao Y, Liang Z, et al
    BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology.
    J Neurochem. 2023 Jun 7. doi: 10.1111/jnc.15870.
    >> Share

  95. HE RB, Li L, Liu LZ, Ma YJ, et al
    Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP/PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR-STEP(61) signaling.
    J Neurochem. 2023 Jun 7. doi: 10.1111/jnc.15874.
    >> Share

  96. BARINGER SL, Simpson IA, Connor JR
    Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    J Neurochem. 2023;165:625-642.
    >> Share

  97. GROVER S, Pham T, Jones A, Sinobas-Pereira C, et al
    A new class of monoclonal Abeta antibodies selectively targets and triggers deposition of Abeta protofibrils.
    J Neurochem. 2023;165:860-873.
    >> Share

  98. DOHERTY G, Holiday A, Malekizadeh Y, Manolescu C, et al
    Leptin-based hexamers facilitate memory and prevent amyloid-driven AMPA receptor internalisation and neuronal degeneration.
    J Neurochem. 2023;165:809-826.
    >> Share

    May 2023
  99. FLEEMAN RM, Kuhn MK, Chan DC, Proctor EA, et al
    Apolipoprotein E epsilon4 modulates astrocyte neuronal support functions in the presence of amyloid-beta.
    J Neurochem. 2023;165:536-549.
    >> Share

    April 2023
  100. MOK KK, Yeung SH, Cheng GW, Ma IW, et al
    Apolipoprotein E epsilon4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport.
    J Neurochem. 2023;165:55-75.
    >> Share

    March 2023
  101. CARNA M, Novotny JS, Dragisic N, Slavik H, et al
    Missorting of Plasma miRNAs in Aging and Alzheimer's Disease.
    J Neurochem. 2023 Mar 9. doi: 10.1111/jnc.15801.
    >> Share

  102. WENZEL TJ, Le J, He J, Alcorn J, et al
    Fundamental Neurochemistry Review: Incorporating a greater diversity of cell types, including microglia, in brain organoid cultures improves clinical translation.
    J Neurochem. 2023;164:560-582.
    >> Share

  103. LOEFFLER DA
    Experimental approaches for altering the expression of Abeta-degrading enzymes.
    J Neurochem. 2023;164:725-763.
    >> Share

  104. SUN Y, Islam S, Gao Y, Nakamura T, et al
    Apolipoprotein E4 inhibits gamma-secretase activity via binding to the gamma-secretase complex.
    J Neurochem. 2023;164:858-874.
    >> Share

  105. TORTUYAUX R, Avila-Gutierrez K, Oudart M, Mazare N, et al
    Physiopathological changes of ferritin mRNA density and distribution in hippocampal astrocytes in the mouse brain.
    J Neurochem. 2023;164:847-857.
    >> Share

    February 2023
  106. HOENIG MC, Drzezga A
    Clear-headed into old age: Resilience and resistance against brain aging-A PET imaging perspective.
    J Neurochem. 2023;164:325-345.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016